European shares cheer Brexit trade talks extension; AstraZeneca drops
Reuters
Published Dec 14, 2020 03:24AM ET
(Reuters) - European shares rose on Monday, as a decision to extend trade talks between Britain and the European Union kept hopes of an eventual deal alive, but London's blue-chips lagged on a higher pound as well as a 6.3% drop in AstraZeneca (NASDAQ:AZN).
The pan-European STOXX 600 index rose 0.9% after breaking a five-week winning streak to end 1% lower last week.
Leaders from both sides decided to extend talks beyond a Sunday deadline in an attempt to secure a deal to govern around $1 trillion in trade, currently free from tariffs and quotas.
The pound, battered recently by the prospect of a chaotic British exit from the bloc, rose more than 1%, weighing on London's export-heavy firms that earn revenue in dollars.
The FTSE 100 was flat as gains in most sectors were offset by a slide in AstraZeneca. The drugmaker said over the weekend, it would buy U.S. drugmaker Alexion Pharmaceuticals (NASDAQ:ALXN) for $39 billion in its largest ever deal.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.